Saturday 31 October 2026 Export BMY’s income statement to Excel — free account

Bristol Myers Squibb Company

BMY Healthcare Drug Manufacturers General

Bristol Myers Squibb Company’s revenue for fiscal 2025 (year ended December 2025) was $48.2 billion, roughly unchanged from fiscal 2024. In the quarter to June 2026, revenue grew 5.74%, EPS grew 153.1%, free cash flow fell 13.2% and total debt fell 12.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

62.55 1.16 +1.89%

Follow BMY

Alert me

Market cap: $125.4B
P/E: 13.8×
Fwd P/E: 11.6×
Dividend yield: 4.03%
F-score: 8/9
Altman Z: 2.14
Beneish M: −2.69
Dividend safety: 63/100

Overview Business Profile Earnings & Analysis Segments Filings

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	12.69	17.04	15.59	15.19	+8 more quarters Free account
P/S ratio Full definition →	2.39	2.55	2.28	1.91
P/FCF ratio Full definition →	10.29	10.38	8.54	6.00
P/Operating CF Full definition →	34.68	111.96	55.58	14.55
P/B ratio Full definition →	5.27	6.15	5.93	4.94
Price to Tangible BV Full definition →	0.00	0.00	0.00	0.00
EV/Sales Full definition →	3.04	3.25	2.99	2.59
EV/EBITDA Full definition →	9.92	11.95	10.81	9.60
EV/Operating CF Full definition →	11.71	11.84	10.18	7.48
EV/FCF Full definition →	13.09	13.23	11.22	8.12
Quick Ratio Full definition →	1.16	1.04	0.94	0.99
Current Ratio Full definition →	1.53	1.42	1.26	1.27
Net Debt/EBITDA Full definition →	6.85	8.86	14.06	7.87
Debt/Assets Full definition →	49.20%	51.41%	50.10%	50.55%
Debt/Equity Full definition →	1.93	2.21	2.44	2.63
Asset Turnover Full definition →	0.54	0.54	0.53	0.50
Operating CF/Net income Full definition →	1.02	0.41	1.82	2.87
Capex/Depreciation Full definition →	(0.51)	(0.58)	(0.38)	(0.32)
Research and Development Expense of Revenue Full definition →	22.81%	23.06%	20.68%	20.68%
Selling, General and Administrative Expense of Revenue Full definition →	14.08%	14.07%	17.45%	14.64%
Intangible Assets out of Total Assets Full definition →	0.45	0.46	0.45	0.44
Share Based Compensation of Revenue Full definition →	1.04%	1.27%	1.06%	1.14%
Graham Net Nets Full definition →	(0.31)	(0.32)	(0.38)	(0.46)
Graham Number Full definition →	33.41	28.11	26.61	24.71
Earnings Yield Full definition →	7.88%	5.87%	6.41%	6.59%
Free Cash Flow Yield Full definition →	9.72%	9.63%	11.71%	16.66%
Revenue per Share Full definition →	6.35	5.64	6.15	6.00
Operating CF per Share Full definition →	1.66	0.54	0.97	3.10
Capex per Share Full definition →	(0.15)	(0.17)	(0.18)	(0.16)
Free Cash Flow per Share Full definition →	1.51	0.37	0.79	2.94
Cash per Share Full definition →	5.42	5.15	5.25	8.11
Shareholders Equity per Share Full definition →	10.93	9.86	9.10	9.14
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	10.93	9.86	9.10	9.14
Free Cash Flow Full definition →	3,088.00	757.00	1,604.00	5,991.00
Working Capital Full definition →	9,920.00	8,050.00	5,973.00	7,494.00
Capital Expenditures Full definition →	(305.00)	(347.00)	(370.00)	(320.00)
Net Current Asset Value Full definition →	(36,736.00)	(39,166.00)	(42,143.00)	(42,659.00)
EV/EBIT Full definition →	12.57	16.42	15.45	15.48
Capex to Sales Full definition →	0.02	0.03	0.03	0.03
Price to Operating Income Full definition →	9.88	12.88	11.76	11.43
Other line items
Average Receivables Full definition →	10,984.00	10,084.50	11,080.50	11,224.00
Average Payables Full definition →	4,792.50	4,118.00	3,588.50	3,878.50
Average Inventory Full definition →	2,737.00	2,711.00	2,623.50	3,045.00
Average Assets Full definition →	91,155.00	89,451.50	91,320.50	95,279.50
Average Common Equity Full definition →	19,904.00	18,774.50	17,446.50	17,899.50

Show all line items

Columns are period end dates

Stockrow Weekly